Epidermal Growth Factor Removal or Tyrphostin AG1478 Treatment Reduces Goblet Cells & Mucus Secretion of Epithelial Cells from Asthmatic Children Using the Air-Liquid Interface Model

• Jeremy C. Parker,

  Affiliation Centre for Infection and Immunity, Health Sciences Building, Queen’s University Belfast, Belfast, Northern Ireland

  ⨯
• Isobel Douglas,

  Affiliation Royal Belfast Hospital for Sick Children, Belfast, Northern Ireland

  ⨯
• Jennifer Bell,

  Affiliation Centre for Infection and Immunity, Health Sciences Building, Queen’s University Belfast, Belfast, Northern Ireland

  ⨯
• David Comer,

  Affiliation Centre for Infection and Immunity, Health Sciences Building, Queen’s University Belfast, Belfast, Northern Ireland

  ⨯
• Keith Bailie,

  Affiliation Royal Belfast Hospital for Sick Children, Belfast, Northern Ireland

  ⨯
• Grzegorz Skibinski,

  Affiliation Centre for Infection and Immunity, Health Sciences Building, Queen’s University Belfast, Belfast, Northern Ireland

  ⨯
• Liam G. Heaney ,

  * E-mail: l.heaney@qub.ac.uk

  ¶‡ These authors are joint senior authors on this work.

  Affiliation Centre for Infection and Immunity, Health Sciences Building, Queen’s University Belfast, Belfast, Northern Ireland

  ⨯
• Michael D. Shields

  ¶‡ These authors are joint senior authors on this work.

  Affiliations Centre for Infection and Immunity, Health Sciences Building, Queen’s University Belfast, Belfast, Northern Ireland, Royal Belfast Hospital for Sick Children, Belfast, Northern Ireland

  ⨯